MSD

Ghana healthcare infrastructure and resource challenges

3 clusters · 9 sources · last updated 4 days ago

Latest: Ghana expands Free Primary Healthcare to 135 districts

Ghana is experiencing a dual reality regarding its primary healthcare system, characterized by infrastructure expansion efforts alongside critical resource shortages. On one hand, the government is actively expanding th

Moderna and Merck melanoma vaccine clinical trials

8 clusters · 443 sources · last updated 5 days ago

Latest: Moderna stock surges following successful melanoma vaccine trials

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target

Ghanaian health policy and regional cooperation

4 clusters · 13 sources · last updated 9 days ago

Latest: Ghana health officials address cancer burden and medical supply stability

Ghanaian health officials are addressing institutional governance, regional regulatory standards, and specific disease burdens. At the 28th Annual International Conference of the Association of Medical Councils of Afri

Alteogen Hybrozyme technology licensing and commercial sales

3 clusters · 5 sources · last updated 10 days ago

Latest: Alteogen signs up to $3.2B licensing deal with Novartis

South Korean biotechnology firm Alteogen has expanded its Hybrozyme platform through significant licensing agreements. In August 2026, the company secured an exclusive licensing deal valued at up to $365 million with a g

South Korean biotechnology and pharmaceutical advancements

2 clusters · 4 sources · last updated 12 days ago

Latest: South Korean biotech firms expand market reach through clinical successes

South Korean biotechnology and pharmaceutical companies are reporting significant clinical advancements and market expansions across various medical sectors. In oncology, the Ministry of Food and Drug Safety approved th